Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease

BACKGROUND: The efficacy of adalimumab in inducing and maintaining remission in children with moderately to severely active Crohn's disease was shown in the IMAgINE 1 trial (NCT00409682). As per protocol, nonresponders or patients experiencing flare(s) on every other week (EOW) maintenance dosi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Inflamm Bowel Dis
Hlavní autoři: Dubinsky, Marla C., Rosh, Joel, Faubion, William A., Kierkus, Jaroslaw, Ruemmele, Frank, Hyams, Jeffrey S., Eichner, Samantha, Li, Yao, Huang, Bidan, Mostafa, Nael M., Lazar, Andreas, Thakkar, Roopal B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2016
Témata:
Original Clinical Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794130/
https://ncbi.nlm.nih.gov/pubmed/26950307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000715
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky